Ameriprise’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-714,213
| Closed | -$907K | – | 4052 |
|
|
2021
Q4 | $907K | Buy |
714,213
+24,100
| +3% | +$43.1K | ﹤0.01% | 3299 |
|
|
2021
Q3 | $1.5M | Sell |
690,113
-14,303
| -2% | -$39.1K | ﹤0.01% | 2981 |
|
|
2021
Q2 | $2.64M | Buy |
704,416
+64,802
| +10% | +$225K | ﹤0.01% | 2805 |
|
|
2021
Q1 | $2.08M | Buy |
639,614
+29,627
| +5% | +$106K | ﹤0.01% | 2843 |
|
|
2020
Q4 | $2.08M | Sell |
609,987
-108,887
| -15% | -$448K | ﹤0.01% | 2782 |
|
|
2020
Q3 | $2.93M | Buy |
718,874
+108,448
| +18% | +$412K | ﹤0.01% | 2440 |
|
|
2020
Q2 | $2.06M | Buy |
610,426
+64,163
| +12% | +$187K | ﹤0.01% | 2589 |
|
|
2020
Q1 | $1.27M | Sell |
546,263
-37,426
| -6% | -$102K | ﹤0.01% | 2715 |
|
|
2019
Q4 | $2.12M | Sell |
583,689
-14,910
| -2% | -$120K | ﹤0.01% | 2708 |
|
|
2019
Q3 | $4.96M | Buy |
598,599
+4,886
| +0.8% | +$39.5K | ﹤0.01% | 2209 |
|
|
2019
Q2 | $5.11M | Sell |
593,713
-6,445
| -1% | -$57.6K | ﹤0.01% | 2242 |
|
|
2019
Q1 | $6.42M | Buy |
600,158
+11,415
| +2% | +$122K | ﹤0.01% | 2059 |
|
|
2018
Q4 | $5.15M | Buy |
588,743
+15,732
| +3% | +$200K | ﹤0.01% | 2101 |
|
|
2018
Q3 | $9.63M | Buy |
573,011
+41,375
| +8% | +$895K | ﹤0.01% | 1892 |
|
|
2018
Q2 | $11.1M | Buy |
531,636
+57,010
| +12% | +$1.06M | ﹤0.01% | 1646 |
|
|
2018
Q1 | $7.64M | Buy |
474,626
+10,870
| +2% | +$215K | ﹤0.01% | 1862 |
|
|
2017
Q4 | $8.79M | Buy |
463,756
+67,425
| +17% | +$1.22M | ﹤0.01% | 1704 |
|
|
2017
Q3 | $5.58M | Buy |
396,331
+20,056
| +5% | +$181K | ﹤0.01% | 2014 |
|
|
2017
Q2 | $2.81M | Sell |
376,275
-110
| -0% | -$719 | ﹤0.01% | 2434 |
|
|
2017
Q1 | $2.45M | Buy |
376,385
+21,405
| +6% | +$120K | ﹤0.01% | 2488 |
|
|
2016
Q4 | $1.57M | Buy |
354,980
+4,894
| +1% | +$20.5K | ﹤0.01% | 2739 |
|
|
2016
Q3 | $1.64M | Buy |
350,086
+55,017
| +19% | +$326K | ﹤0.01% | 2669 |
|
|
2016
Q2 | $1.94M | Buy |
295,069
+16,855
| +6% | +$119K | ﹤0.01% | 2540 |
|
|
2016
Q1 | $1.77M | Buy |
278,214
+1,809
| +0.7% | +$9.28K | ﹤0.01% | 2582 |
|
|
2015
Q4 | $1.67M | Sell |
276,405
-12,189
| -4% | -$69.7K | ﹤0.01% | 2703 |
|
|
2015
Q3 | $1.73M | Sell |
288,594
-10,133
| -3% | -$70.3K | ﹤0.01% | 2694 |
|
|
2015
Q2 | $2.04M | Buy |
298,727
+18,084
| +6% | +$115K | ﹤0.01% | 2744 |
|
|
2015
Q1 | $1.7M | Sell |
280,643
-529
| -0.2% | -$3.52K | ﹤0.01% | 2663 |
|
|
2014
Q4 | $1.95M | Buy |
281,172
+7,064
| +3% | +$51.9K | ﹤0.01% | 2576 |
|
|
2014
Q3 | $2.23M | Buy |
274,108
+40,338
| +17% | +$316K | ﹤0.01% | 2470 |
|
|
2014
Q2 | $1.9M | Buy |
233,770
+12,060
| +5% | +$91.5K | ﹤0.01% | 2548 |
|
|
2014
Q1 | $1.74M | Buy |
221,710
+8,600
| +4% | +$72.8K | ﹤0.01% | 2539 |
|
|
2013
Q4 | $1.89M | Buy |
213,110
+8,023
| +4% | +$71.7K | ﹤0.01% | 2488 |
|
|
2013
Q3 | $1.72M | Buy |
205,087
+10,075
| +5% | +$81.6K | ﹤0.01% | 2510 |
|
|
2013
Q2 | $1.46M | Buy |
+195,012
| New | +$1.5M | ﹤0.01% | 2486 |
|
Other funds holding SPPI
AC
ACM
Ameriprise's SPPI Position: Q1 2022 in Review
Ameriprise sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 714,213 shares — an estimated $907K sold.
Ameriprise first reported a position in SPPI in Q2 2013 and held it in 35 quarters. The position peaked at $11.1M in Q2 2018. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.
- Ameriprise reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Ameriprise sold 714,213 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $907K.
- Ameriprise first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Ameriprise's Spectrum Pharmaceuticals Inc position peaked at $11.1M in Q2 2018.
- 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.
Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.